BDSX

Biodesix Inc

23.25

Oct 30 • 3:59 PM ET -1.47 (-5.93%)

23.72

Aftermarket • 7:30 PM ET +0.47 (2.00%)

Healthcare Diagnostics & Research USA Micro NASD

Peers: VCYT BIAF GH NEO CSTL XGN IMDX GRAL MDXH QTRX

| Held by: VTI VXF IWC BUSM GNMX

Scroll to Statements

Index	-
Market Cap	245.37M
Enterprise Value	287.07M
Income	-27.76M
Sales	102.94M
Book/sh	0.87
Cash/sh	2.85
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	334
IPO	Oct 28, 2020

P/E	-
Forward P/E	-
PEG	-
P/S	2.38
P/B	26.83
P/C	8.15
P/FCF	-
EV/EBITDA	-
EV/Sales	2.79
Quick Ratio	2.77
Current Ratio	2.85
Debt/Eq	7.86
LT Debt/Eq	7.68
Option/Short	No / Yes

EPS (ttm)	-3.17
EPS next Y	-1.67
EPS next Q	-0.75
EPS this Y	42.80%
EPS next Y	37.54%
EPS next 5Y	39.91%
EPS past 3/5Y	46.84% 27.68%
Sales past 3/5Y	32.31% 14.20%
EPS Y/Y TTM	43.48%
Sales Y/Y TTM	34.46%
EPS Q/Q	54.83%
Sales Q/Q	34.18%
Earnings	Nov 05 AMC
EPS/Sales Surpr.	21.27% 3.21%

Insider Own	55.58%
Insider Trans	0.73%
Inst Own	41.34%
Inst Trans	3.61%
ROA	-30.33%
ROE	-540.01%
ROIC	-35.00%
Gross Margin	82.50%
Oper. Margin	-19.99%
Profit Margin	-26.97%
SMA20	-4.79%
SMA50	-12.11%
SMA200	24.55%
Trades

Shs Outstand	10.55M
Shs Float	4.69M
Short Float	4.47%
Short Ratio	2.03
Short Interest	0.21M
52W High	31.97 -27.26%
52W Low	5.26 342.11%
Volatility	8.96% 7.49%
ATR (14)	1.89
RSI (14)	43.98
Beta	0.61
Rel Volume	0.65
Avg Volume	103.35K
Volume	67,266

Perf Week	9.80%
Perf Month	-14.91%
Perf Quarter	5.56%
Perf Half Y	109.88%
Perf YTD	241.99%
Perf Year	253.96%
Perf 3Y	-21.44%
Perf 5Y	-84.58%
Perf 10Y	-
Recom	1.00
Target Price	39.00
Prev Close	24.72
Price	23.25
Change %	-5.93%

Consensus

Strong Buy

Avg. Price Target

$39.00

Implied Upside

+67.7%

Analysts10incl. previous ratings

Rating Distribution9 Buy · 1 Hold · 0 Sell

Date	Action	Analyst	Rating Change	Price Target Change	Implied Upside
Jun 25, 2026	Initiated	RRoth Capital	Buy	$32	+37.6%
Jun 15, 2026	Initiated	HH.C. Wainwright	Buy	$26	+11.8%
Feb 27, 2026	Upgrade	WWilliam Blair	Mkt Perform → Outperform
May 14, 2025	Downgrade	WWilliam Blair	Outperform → Mkt Perform
Sep 16, 2024	Initiated	BScotiabank	Sector Outperform
Jul 26, 2024	Initiated	CCraig Hallum	Buy	$3	-87.1%
May 13, 2024	Initiated	TTD Cowen	Buy	$2.80	-88.0%
May 03, 2024	Initiated	LLake Street	Buy	$3	-87.1%
Nov 17, 2021	Downgrade	MMorgan Stanley	Overweight → Equal-Weight	$21 → $11	-52.7%
Nov 23, 2020	Initiated	WWilliam Blair	Outperform
Nov 23, 2020	Initiated	MMorgan Stanley	Overweight	$20	-14.0%
Nov 23, 2020	Initiated	CCanaccord Genuity	Buy	$26	+11.8%
Nov 23, 2020	Initiated	BBTIG Research	Buy	$22	-5.4%

Oct-28-26 06:46PM	Biodesix Must Show Its Lung Nodule Test Surge Can Outrun A Shrinking Pharma Backlog (Earnings Whispers) +8.14%
Oct-22-26 06:00AM	Biodesix to Report Third Quarter 2026 Financial Results on November 5, 2026 (GlobeNewswire)
Oct-19-26 04:01PM	American College of Chest Physicians Publishes New Framework for Lung Nodule Programs Recommending Biomarkers for Risk Stratification (GlobeNewswire)
06:00AM	Biodesix Adds Digital Diagnostics to Lung Pipeline, Creating New Growth Platform Combining Blood and Imaging Biomarkers (GlobeNewswire)
Oct-13-26 06:00AM	Biodesix to Present New Real-World Evidence Supporting Integration of Nodify Lung Testing into Routine Lung Nodule Care at CHEST 2026 (GlobeNewswire)
06:34AM	Loading…
Sep-24-26 06:34AM	Biodesix Advances MRD Monitoring Programs With Bio-Rad and Thermo Fisher (InvestorsHub)
06:00AM	Biodesix Advances Two Complementary Approaches to Molecular Residual Disease (MRD) Monitoring (GlobeNewswire)
Sep-14-26 04:01PM	Biodesix Quality and Regulatory Executive, Brianna Phillips, to speak at upcoming RAPS and SOCRA Annual Meetings (GlobeNewswire)
Sep-03-26 06:00AM	Biodesix to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-06-26 01:08AM	Biodesix Inc (BDSX) (Q2 2026) Earnings Call Highlights: Revenue Surges 34% on Strong Diagnostic ... (GuruFocus.com)
Aug-05-26 04:01PM	Biodesix Announces Second Quarter 2026 Results and Highlights (GlobeNewswire)
Aug-04-26 09:48AM	Earnings To Watch: Biodesix Inc (BDSX) Q2 2026 -- GF Value Sees 6% Upside (GuruFocus.com)
06:00AM	Biodesix to Participate in Canaccord Genuity's 46th Annual Growth Conference (GlobeNewswire)
Jul-22-26 06:00AM	Biodesix to Report Second Quarter 2026 Financial Results on August 5, 2026 (GlobeNewswire)
May-21-26 06:00AM	Biodesix to Participate in Upcoming Investor Conferences (GlobeNewswire) +5.64%
09:17AM	Loading…
May-11-26 09:17AM	Biodesix Announces ATS 2026 Presentations Providing Real-World Clinical Evidence and Healthcare System Economic Value for Nodify Lung Testing Strategy (GlobeNewswire) +5.16%
May-04-26 04:01PM	Biodesix Announces First Quarter 2026 Results and Highlights (GlobeNewswire) +32.56%
May-01-26 09:19AM	Earnings To Watch: Biodesix Inc (BDSX) Reports Q1 2026 Result (GuruFocus.com)
Apr-23-26 12:33PM	SkylineDx Presents Gene Expression Profiling for Skin Cancer Metastases (Exec Edge) -13.99%
Apr-20-26 06:00AM	Biodesix to Report First Quarter 2026 Financial Results on May 4, 2026 (GlobeNewswire)
Apr-09-26 01:19PM	Biodesix Recognized as a Top Workplace for Third Consecutive Year (GlobeNewswire) -6.53%
Apr-06-26 11:43AM	Biodesix Announces AACR 2026 Posters and Presentations, Highlighting Novel Diagnostic Test Discovery & Pipeline Development (GlobeNewswire)
Mar-20-26 08:06AM	Biodesix Announces the Largest Lung Nodule Biomarker Clinical Validation Study Ever Published Supporting Earlier Lung Cancer Diagnosis (GlobeNewswire) -8.74%
Mar-06-26 07:38AM	Biodesix Details Lung Nodule Growth Plan, Primary Care Push at TD Cowen Healthcare Conference (MarketBeat) +18.41%
Mar-03-26 09:55AM	Wall Street Analysts Think Biodesix (BDSX) Could Surge 111.62%: Read This Before Placing a Bet (Zacks)
09:40AM	Are Medical Stocks Lagging Biodesix (BDSX) This Year? (Zacks)
Feb-27-26 12:04AM	Biodesix Inc (BDSX) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com) +7.81%
Feb-26-26 05:48PM	Biodesix Q4 Earnings Call Highlights (MarketBeat) +9.98%
05:15PM	Biodesix, Inc. (BDSX) Reports Q4 Loss, Beats Revenue Estimates (Zacks)
04:01PM	Biodesix Announces Fourth Quarter and Fiscal Year 2025 Results and Highlights (GlobeNewswire)
07:42AM	Loading…
Feb-25-26 07:42AM	Earnings To Watch: Biodesix Inc (BDSX) Reports Q4 2025 Result (GuruFocus.com)
Feb-24-26 06:00AM	Biodesix to Participate in Upcoming Investor Conferences (GlobeNewswire)
Feb-12-26 06:00AM	Biodesix to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 (GlobeNewswire)
Jan-31-26 08:15AM	Insiders Are Still Scooping Up Under Armour and WR Berkley Shares (24/7 Wall St.)
Jan-12-26 06:00AM	Biodesix Announces Preliminary Fourth Quarter and Full-Year 2025 Results (Unaudited) (GlobeNewswire) +47.99%
Dec-24-25 01:48PM	SOLV Acquires Acera Surgical to Expand Advanced Wound Care Portfolio (Zacks)
Dec-19-25 11:05AM	Cencora to Acquire OneOncology to Expand Community Oncology Solutions (Zacks) -5.77%
Dec-03-25 09:55AM	Wall Street Analysts Believe Biodesix (BDSX) Could Rally 325.67%: Here's is How to Trade (Zacks)
08:22AM	Biodesix to Present New Data at Two Major Upcoming Scientific Meetings (GlobeNewswire)
Nov-04-25 12:01AM	Biodesix Inc (BDSX) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Rising Costs (GuruFocus.com) +19.87%
Nov-03-25 05:30PM	Biodesix, Inc. (BDSX) Reports Q3 Loss, Tops Revenue Estimates (Zacks) -7.17%
04:01PM	Biodesix Announces Third Quarter 2025 Results and Highlights (GlobeNewswire)
Oct-31-25 09:35AM	What To Expect From Biodesix Inc (BDSX) Q3 2025 Earnings (GuruFocus.com)
Oct-30-25 06:17AM	Biodesix to Share its R&D Roadmap during its Corporate Day Presentation at AMP Annual Meeting (GlobeNewswire)
Oct-29-25 05:45PM	Teladoc (TDOC) Reports Q3 Loss, Beats Revenue Estimates (Zacks)
Oct-27-25 07:10AM	Revvity (RVTY) Surpasses Q3 Earnings Estimates (Zacks)
Oct-22-25 06:17AM	Biodesix Announces Expanded Bio-Rad Laboratories Partnership Agreement to Develop Droplet Digital PCR High Complexity Assays (GlobeNewswire) -12.15%
Oct-20-25 06:00AM	Biodesix to Report Third Quarter 2025 Financial Results on November 3, 2025 (GlobeNewswire)
Oct-15-25 06:09AM	Biodesix Announces Presentations and Events at the CHEST 2025 Annual Meeting (GlobeNewswire)
Oct-06-25 10:13AM	Biodesix Unveils October Lung Health Events in Colorado with the Association of Pulmonary Advanced Practice Providers (APAPP), American Lung Association in Colorado, and GO2 for Lung Cancer Centers of Excellence Summit (GlobeNewswire)
Sep-11-25 08:00AM	Biodesix Announces One-for-Twenty Reverse Stock Split (GlobeNewswire) -20.82%
Sep-05-25 06:00AM	Biodesix to Participate in Lake Street Capital Markets' 9th Annual Best Ideas Growth (BIG9) Conference (GlobeNewswire)
Sep-04-25 10:30AM	BC-Most Active Stocks (Associated Press Finance) +5.05%
Aug-19-25 09:47AM	Biodesix Recognized as a Thermo Fisher Scientific Center of Excellence (COE) for NGS Diagnostics (GlobeNewswire)
Aug-07-25 05:20PM	Biodesix, Inc. (BDSX) Reports Q2 Loss, Tops Revenue Estimates (Zacks) +14.62% -10.40%
04:06PM	Biodesix Announces Second Quarter 2025 Results and Highlights (GlobeNewswire)
Aug-05-25 06:00AM	Biodesix to Present at the Canaccord Genuity 45th Annual Growth Conference (GlobeNewswire) +10.10%
Aug-01-25 07:15AM	Avantor, Inc. (AVTR) Q2 Earnings Lag Estimates (Zacks)
Jul-25-25 12:22PM	Biodesix, APAPP Partner to Launch First CME-Accredited Education Program for Lung Cancer Biomarkers (Insider Monkey) +6.80%
12:22PM	Sangamo Therapeutics Announces Positive Phase 1/2 STAAR Study Results for Fabry Gene Therapy (Insider Monkey)
Jul-24-25 06:00AM	Biodesix to Report Second Quarter 2025 Financial Results on August 7, 2025 (GlobeNewswire)
Jun-10-25 06:17AM	Biodesix Partners with Association of Pulmonary Advanced Practice Providers (APAPP) to Deliver Nation's First Medical Education for APPs on Biomarkers in Lung Nodule and Lung Cancer Programs (GlobeNewswire) +13.91%
May-22-25 05:03PM	Biodesix Announces New Data on the VeriStrat Test to be Presented at the 2025 ASCO Annual Meeting (GlobeNewswire) -9.92%
May-21-25 06:00AM	Biodesix to Participate in Upcoming Investor Conferences (GlobeNewswire) +45.90%
May-15-25 06:00AM	Biodesix Announces New Clinical and Economic Data for its Nodify Lung Tests at ISPOR and ATS (GlobeNewswire)
May-14-25 04:01PM	Denver Post Names Biodesix a Winner of Top Workplaces 2025 Award (GlobeNewswire) -38.74%
03:16AM	Biodesix Inc (BDSX) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Sales Team ... (GuruFocus.com)
May-13-25 05:15PM	Biodesix, Inc. (BDSX) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:01PM	Biodesix Announces First Quarter 2025 Results and Highlights (GlobeNewswire)
May-12-25 09:50AM	Biodesix Inc (BDSX) Q1 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
09:25AM	Sonida Senior Living (SNDA) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
May-08-25 06:30PM	DocGo Inc. (DCGO) Reports Q1 Loss, Misses Revenue Estimates (Zacks) -17.91% +6.84%
Apr-30-25 07:45AM	GeneDx Holdings Corp. (WGS) Q1 Earnings and Revenues Surpass Estimates (Zacks)
Apr-29-25 06:00AM	Biodesix to Report First Quarter 2025 Financial Results on May 13, 2025 (GlobeNewswire) -6.51%
Apr-28-25 07:15AM	Revvity (RVTY) Beats Q1 Earnings and Revenue Estimates (Zacks) +6.25%
Apr-25-25 07:15AM	Avantor, Inc. (AVTR) Q1 Earnings Meet Estimates (Zacks) -5.64%
Apr-23-25 06:00AM	Biodesix partner, Friends of Cancer Research, publishes data in Clinical Cancer Research, demonstrating strong association between ctDNA changes and treatment outcomes for patients with solid tumor types (GlobeNewswire)
Mar-06-25 12:00PM	Biodesix (BDSX) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
Mar-04-25 05:20AM	Biodesix, Inc. (BDSX): Among Penny Stocks with Insider Buying in 2025 (Insider Monkey)
02:03AM	Biodesix Inc (BDSX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
Mar-03-25 04:01PM	Biodesix Announces Fourth Quarter and Fiscal Year 2024 Results (GlobeNewswire) -10.09%
Feb-28-25 07:15AM	Biodesix Inc (BDSX) Q4 2024: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Feb-26-25 06:00AM	Biodesix to Present at TD Cowen 45th Annual Health Care Conference (GlobeNewswire)
Feb-18-25 06:00AM	Biodesix to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025 (GlobeNewswire)
Jan-10-25 06:00AM	Biodesix Announces Preliminary Fourth Quarter and Full-Year 2024 Results (Unaudited) (GlobeNewswire) -14.19%
Jan-07-25 06:00AM	Biodesix Announces Publication of a New Nodify CDT Clinical Validation Study (GlobeNewswire)
Nov-20-24 09:35AM	Biodesix (BDSX) Loses -22.98% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks)
Nov-02-24 03:01AM	Biodesix Inc (BDSX) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Operational ... (GuruFocus.com)
Nov-01-24 07:15AM	Biodesix, Inc. (BDSX) Reports Q3 Loss, Misses Revenue Estimates (Zacks) -23.53%
06:00AM	Biodesix Announces Third Quarter 2024 Results and Highlights (GlobeNewswire)
Oct-31-24 09:06AM	What To Expect From Biodesix Inc (BDSX) Q3 2024 Earnings (GuruFocus.com)
Oct-29-24 06:00AM	Biodesix to Participate in Three Investor Conferences in November (GlobeNewswire)
Oct-18-24 06:00AM	Biodesix to Report Third Quarter 2024 Financial Results on November 1, 2024 (Business Wire)
Oct-07-24 06:00AM	Biodesix Announces New Data Presentation at CHEST 2024 Annual Meeting and the Launch of a Complementary Clinical Study (Business Wire)
Sep-05-24 06:00AM	Biodesix to Present at Two Investor Conferences in September (Business Wire)
Aug-08-24 10:23AM	Q2 2024 Biodesix Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-07-24 06:05PM	Biodesix, Inc. (BDSX) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:01PM	Biodesix Announces Second Quarter 2024 Results and Highlights (Business Wire)
Aug-06-24 06:00AM	Biodesix to Present at Canaccord Genuitys 44th Annual Growth Conference (Business Wire)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
SCHULER JACK W	Emeritus Director	Aug 12 '26	Buy	24.47	15,000	366,992	555,810	Aug 13 05:22 PM
SCHULER JACK W	Emeritus Director	Aug 10 '26	Buy	24.25	13,900	337,029	527,110	Aug 12 05:55 PM
SCHULER JACK W	Emeritus Director	Aug 11 '26	Buy	24.01	13,700	328,911	540,810	Aug 12 05:55 PM
Pestano Gary Anthony	Chief Development Officer	Feb 23 '26	Sale	12.78	556	7,103	10,359	Feb 23 08:22 PM
O'Kane Kieran	Chief Commercial Officer	Feb 23 '26	Sale	12.78	535	6,835	9,819	Feb 23 08:22 PM
Cowie Robin Harper	CFO, Sec'y & Treasurer	Feb 23 '26	Sale	12.78	535	6,835	16,231	Feb 23 08:22 PM
Vazquez Chris	Chief Accounting Officer	Feb 23 '26	Sale	12.78	211	2,696	1,586	Feb 23 08:22 PM
Hutton Scott	President & CEO	Feb 23 '26	Sale	12.78	1,490	19,036	48,767	Feb 23 08:22 PM
Hutton Scott	Officer	Feb 23 '26	Proposed Sale	12.77	1,490	19,027		Feb 23 08:22 PM
O'Kane Kieran	Chief Commercial Officer	Feb 10 '26	Sale	10.08	584	5,889	8,885	Feb 11 06:03 PM
Vazquez Chris	Chief Accounting Officer	Feb 10 '26	Sale	10.08	101	1,018	1,234	Feb 11 06:03 PM
Hutton Scott	President & CEO	Feb 10 '26	Sale	10.08	3,559	35,889	45,413	Feb 11 06:03 PM
Cowie Robin Harper	CFO, Sec'y & Treasurer	Feb 10 '26	Sale	10.08	941	9,489	15,297	Feb 11 06:03 PM
Pestano Gary Anthony	Chief Development Officer	Feb 10 '26	Sale	10.08	540	5,445	9,387	Feb 11 06:03 PM
SCHULER JACK W	Emeritus Director	Jan 23 '26	Buy	11.81	80,000	944,672	1,543,210	Jan 27 09:29 AM
SCHULER JACK W	Emeritus Director	Jan 26 '26	Buy	11.80	20,000	236,064	1,563,210	Jan 27 09:29 AM
SCHULER JACK W	Emeritus Director	Jan 22 '26	Buy	10.96	82,465	903,561	1,463,210	Jan 26 09:28 AM
Vazquez Chris	Chief Accounting Officer	Jan 16 '26	Sale	8.15	83	676	1,072	Jan 20 04:22 PM
Pestano Gary Anthony	Chief Development Officer	Jan 16 '26	Sale	8.15	298	2,428	8,446	Jan 20 04:21 PM
O'Kane Kieran	Chief Commercial Officer	Jan 16 '26	Sale	8.15	298	2,428	7,869	Jan 20 04:21 PM
Hutton Scott	President & CEO	Jan 16 '26	Sale	8.15	970	7,905	38,974	Jan 20 04:21 PM
Cowie Robin Harper	CFO, Sec'y & Treasurer	Jan 16 '26	Sale	8.15	298	2,428	13,654	Jan 20 04:21 PM
Vazquez Chris	Chief Accounting Officer	Nov 10 '25	Sale	7.62	13	99	936	Nov 13 04:54 PM
Pestano Gary Anthony	Chief Development Officer	Nov 10 '25	Sale	7.62	23	175	7,939	Nov 13 04:54 PM
O'Kane Kieran	Chief Commercial Officer	Nov 10 '25	Sale	7.62	25	190	7,362	Nov 13 04:53 PM
Hutton Scott	President & CEO	Nov 10 '25	Sale	7.62	189	1,440	37,311	Nov 13 04:53 PM
Cowie Robin Harper	CFO, Sec'y & Treasurer	Nov 10 '25	Sale	7.62	50	381	13,147	Nov 13 04:53 PM

Biodesix, Inc. operates as a diagnostic solutions company. It engages in providing blood-based diagnostic tests and development services. The firm offers five diagnostic tests, including Nodify CDT, Nodify XL2, GeneStrat ddPCR, GeneStrat NGS, and VeriStrat. The company was founded by David Brunel and Robert E. Cawthorn in 2005 and is headquartered in Louisville, CO.

PresidentMr. Scott Hutton

CFOMs. Robin Harper Cowie

Chief Commercial OfficerMr. Kieran O'Kane

Founder & CTODr. Heinrich Roder D.Phil

Chief Scientific OfficerDr. Gary Anthony Pestano Ph.D.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BDSX

Biodesix Inc

Upgrade your Finviz experience